Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Alpha-1 antitrypsin deficiency: outstanding questions and future directions.

Torres-Durán M, Lopez-Campos JL, Barrecheguren M, Miravitlles M, Martinez-Delgado B, Castillo S, Escribano A, Baloira A, Navarro-Garcia MM, Pellicer D, Bañuls L, Magallón M, Casas F, Dasí F.

Orphanet J Rare Dis. 2018 Jul 11;13(1):114. doi: 10.1186/s13023-018-0856-9. Review.

2.

Characterization of Novel Missense Variants of SERPINA1 Gene Causing Alpha-1 Antitrypsin Deficiency.

Matamala N, Lara B, Gomez-Mariano G, Martínez S, Retana D, Fernandez T, Silvestre RA, Belmonte I, Rodriguez-Frias F, Vilar M, Sáez R, Iturbe I, Castillo S, Molina-Molina M, Texido A, Tirado-Conde G, Lopez-Campos JL, Posada M, Blanco I, Janciauskiene S, Martinez-Delgado B.

Am J Respir Cell Mol Biol. 2018 Jun;58(6):706-716. doi: 10.1165/rcmb.2017-0179OC.

PMID:
29232161
3.

Identification of Novel Short C-Terminal Transcripts of Human SERPINA1 Gene.

Matamala N, Aggarwal N, Iadarola P, Fumagalli M, Gomez-Mariano G, Lara B, Martinez MT, Cuesta I, Stolk J, Janciauskiene S, Martinez-Delgado B.

PLoS One. 2017 Jan 20;12(1):e0170533. doi: 10.1371/journal.pone.0170533. eCollection 2017.

4.

Spanish Registry of Patients With Alpha-1 Antitrypsin Deficiency: Database Evaluation and Population Analysis.

Lara B, Blanco I, Martínez MT, Rodríguez E, Bustamante A, Casas F, Cadenas S, Hernández JM, Lázaro L, Torres M, Curi S, Esquinas C, Dasí F, Escribano A, Herrero I, Martínez-Delgado B, Michel FJ, Rodríguez-Frías F, Miravitlles M.

Arch Bronconeumol. 2017 Jan;53(1):13-18. doi: 10.1016/j.arbres.2016.05.003. Epub 2016 Jun 17. English, Spanish.

5.

Alpha-1 Antitrypsin Regulates Transcriptional Levels of Serine Proteases in Blood Mononuclear Cells.

Aggarwal N, Koepke J, Matamala N, Martinez-Delgado B, Martinez MT, Golpon H, Stolk J, Janciauskiene S, Koczulla R.

Am J Respir Crit Care Med. 2016 May 1;193(9):1065-7. doi: 10.1164/rccm.201510-2062LE. No abstract available.

PMID:
27128707
6.

MicroRNA deregulation in triple negative breast cancer reveals a role of miR-498 in regulating BRCA1 expression.

Matamala N, Vargas MT, González-Cámpora R, Arias JI, Menéndez P, Andrés-León E, Yanowsky K, Llaneza-Folgueras A, Miñambres R, Martínez-Delgado B, Benítez J.

Oncotarget. 2016 Apr 12;7(15):20068-79. doi: 10.18632/oncotarget.7705.

7.

miRNA expression profiling of formalin-fixed paraffin-embedded (FFPE) hereditary breast tumors.

Tanić M, Yanowski K, Andrés E, Gómez-López G, Socorro MR, Pisano DG, Martinez-Delgado B, Benítez J.

Genom Data. 2014 Nov 22;3:75-9. doi: 10.1016/j.gdata.2014.11.008. eCollection 2015 Mar.

8.

Alternative transcripts of the SERPINA1 gene in alpha-1 antitrypsin deficiency.

Matamala N, Martínez MT, Lara B, Pérez L, Vázquez I, Jimenez A, Barquín M, Ferrarotti I, Blanco I, Janciauskiene S, Martinez-Delgado B.

J Transl Med. 2015 Jul 4;13:211. doi: 10.1186/s12967-015-0585-y.

9.

Tumor microRNA expression profiling identifies circulating microRNAs for early breast cancer detection.

Matamala N, Vargas MT, González-Cámpora R, Miñambres R, Arias JI, Menéndez P, Andrés-León E, Gómez-López G, Yanowsky K, Calvete-Candenas J, Inglada-Pérez L, Martínez-Delgado B, Benítez J.

Clin Chem. 2015 Aug;61(8):1098-106. doi: 10.1373/clinchem.2015.238691. Epub 2015 Jun 8.

10.

Severe alpha-1 antitrypsin deficiency in composite heterozygotes inheriting a new splicing mutation QOMadrid.

Lara B, Martínez MT, Blanco I, Hernández-Moro C, Velasco EA, Ferrarotti I, Rodriguez-Frias F, Perez L, Vazquez I, Alonso J, Posada M, Martínez-Delgado B.

Respir Res. 2014 Oct 7;15:125. doi: 10.1186/s12931-014-0125-y.

11.

MicroRNA profile in very young women with breast cancer.

Peña-Chilet M, Martínez MT, Pérez-Fidalgo JA, Peiró-Chova L, Oltra SS, Tormo E, Alonso-Yuste E, Martinez-Delgado B, Eroles P, Climent J, Burgués O, Ferrer-Lozano J, Bosch A, Lluch A, Ribas G.

BMC Cancer. 2014 Jul 21;14:529. doi: 10.1186/1471-2407-14-529.

12.

MicroRNA expression signatures for the prediction of BRCA1/2 mutation-associated hereditary breast cancer in paraffin-embedded formalin-fixed breast tumors.

Tanic M, Yanowski K, Gómez-López G, Rodriguez-Pinilla MS, Marquez-Rodas I, Osorio A, Pisano DG, Martinez-Delgado B, Benítez J.

Int J Cancer. 2015 Feb 1;136(3):593-602. doi: 10.1002/ijc.29021. Epub 2014 Jun 19.

13.

Alpha-1-antitrypsin deficiency associated with the Mattawa variant.

Lara B, Martínez-Delgado B, Torres ML, Marín-Arguedas S, Bustamante A, Miravitlles M.

Arch Bronconeumol. 2013 Dec;49(12):548-50. doi: 10.1016/j.arbres.2013.05.004. Epub 2013 Oct 31.

14.

MicroRNA-based molecular classification of non-BRCA1/2 hereditary breast tumours.

Tanic M, Andrés E, Rodriguez-Pinilla SM, Marquez-Rodas I, Cebollero-Presmanes M, Fernandez V, Osorio A, Benítez J, Martinez-Delgado B.

Br J Cancer. 2013 Nov 12;109(10):2724-34. doi: 10.1038/bjc.2013.612. Epub 2013 Oct 8.

15.

Short telomeres are frequent in hereditary breast tumors and are associated with high tumor grade.

Martinez-Delgado B, Gallardo M, Tanic M, Yanowsky K, Inglada-Perez L, Barroso A, Rodriguez-Pinilla M, Cañamero M, Blasco MA, Benitez J.

Breast Cancer Res Treat. 2013 Sep;141(2):231-42. doi: 10.1007/s10549-013-2696-6. Epub 2013 Sep 15.

PMID:
24036693
16.

Mutational analysis of telomere genes in BRCA1/2-negative breast cancer families with very short telomeres.

Yanowsky K, Barroso A, Osorio A, Urioste M, Benitez J, Martinez-Delgado B.

Breast Cancer Res Treat. 2012 Aug;134(3):1337-43. doi: 10.1007/s10549-012-2141-2. Epub 2012 Jul 3.

PMID:
22752289
17.

Deregulated miRNAs in hereditary breast cancer revealed a role for miR-30c in regulating KRAS oncogene.

Tanic M, Yanowsky K, Rodriguez-Antona C, Andrés R, Márquez-Rodas I, Osorio A, Benitez J, Martinez-Delgado B.

PLoS One. 2012;7(6):e38847. doi: 10.1371/journal.pone.0038847. Epub 2012 Jun 11.

18.

Shorter telomere length is associated with increased ovarian cancer risk in both familial and sporadic cases.

Martinez-Delgado B, Yanowsky K, Inglada-Perez L, de la Hoya M, Caldes T, Vega A, Blanco A, Martin T, Gonzalez-Sarmiento R, Blasco M, Robledo M, Urioste M, Song H, Pharoah P, Benitez J.

J Med Genet. 2012 May;49(5):341-4. doi: 10.1136/jmedgenet-2012-100807. Epub 2012 Apr 6.

PMID:
22493152
19.

Integration of BRCA1-mediated miRNA and mRNA profiles reveals microRNA regulation of TRAF2 and NFκB pathway.

Tanic M, Zajac M, Gómez-López G, Benítez J, Martínez-Delgado B.

Breast Cancer Res Treat. 2012 Jul;134(1):41-51. doi: 10.1007/s10549-011-1905-4. Epub 2011 Dec 14.

PMID:
22167321
20.

Genetic anticipation is associated with telomere shortening in hereditary breast cancer.

Martinez-Delgado B, Yanowsky K, Inglada-Perez L, Domingo S, Urioste M, Osorio A, Benitez J.

PLoS Genet. 2011 Jul;7(7):e1002182. doi: 10.1371/journal.pgen.1002182. Epub 2011 Jul 28.

21.

The miR-200 family controls beta-tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients.

Leskelä S, Leandro-García LJ, Mendiola M, Barriuso J, Inglada-Pérez L, Muñoz I, Martínez-Delgado B, Redondo A, de Santiago J, Robledo M, Hardisson D, Rodríguez-Antona C.

Endocr Relat Cancer. 2010 Dec 21;18(1):85-95. doi: 10.1677/ERC-10-0148. Print 2011 Feb.

22.

Molecular signature of response and potential pathways related to resistance to the HSP90 inhibitor, 17AAG, in breast cancer.

Zajac M, Gomez G, Benitez J, Martínez-Delgado B.

BMC Med Genomics. 2010 Oct 4;3:44. doi: 10.1186/1755-8794-3-44.

23.

Current and future aggressive peripheral T-cell lymphoma treatment paradigms, biological features and therapeutic molecular targets.

Rodríguez J, Gutiérrez A, Martínez-Delgado B, Perez-Manga G.

Crit Rev Oncol Hematol. 2009 Sep;71(3):181-98. doi: 10.1016/j.critrevonc.2008.10.011. Epub 2008 Dec 3. Review.

PMID:
19056295
24.

Mitotic catastrophe cell death induced by heat shock protein 90 inhibitor in BRCA1-deficient breast cancer cell lines.

Zajac M, Moneo MV, Carnero A, Benitez J, Martínez-Delgado B.

Mol Cancer Ther. 2008 Aug;7(8):2358-66. doi: 10.1158/1535-7163.MCT-08-0327.

25.

Evaluation of the BRCA1 interacting genes RAP80 and CCDC98 in familial breast cancer susceptibility.

Osorio A, Barroso A, García MJ, Martínez-Delgado B, Urioste M, Benítez J.

Breast Cancer Res Treat. 2009 Jan;113(2):371-6. doi: 10.1007/s10549-008-9933-4. Epub 2008 Feb 13.

PMID:
18270812
26.

Expression of CYP3A4 as a predictor of response to chemotherapy in peripheral T-cell lymphomas.

Rodríguez-Antona C, Leskelä S, Zajac M, Cuadros M, Alvés J, Moneo MV, Martín C, Cigudosa JC, Carnero A, Robledo M, Benitez J, Martínez-Delgado B.

Blood. 2007 Nov 1;110(9):3345-51. Epub 2007 Jul 18.

27.

Identification of a proliferation signature related to survival in nodal peripheral T-cell lymphomas.

Cuadros M, Dave SS, Jaffe ES, Honrado E, Milne R, Alves J, Rodríguez J, Zajac M, Benitez J, Staudt LM, Martinez-Delgado B.

J Clin Oncol. 2007 Aug 1;25(22):3321-9. Epub 2007 Jun 18.

PMID:
17577022
28.

Peripheral T-cell lymphoma gene expression profiles.

Martinez-Delgado B.

Hematol Oncol. 2006 Sep;24(3):113-9. Review.

PMID:
16676369
29.

A haplotype containing the p53 polymorphisms Ins16bp and Arg72Pro modifies cancer risk in BRCA2 mutation carriers.

Osorio A, Martínez-Delgado B, Pollán M, Cuadros M, Urioste M, Torrenteras C, Melchor L, Díez O, De La Hoya M, Velasco E, González-Sarmiento R, Caldés T, Alonso C, Benítez J.

Hum Mutat. 2006 Mar;27(3):242-8.

PMID:
16419081
30.

Differential expression of NF-kappaB pathway genes among peripheral T-cell lymphomas.

Martínez-Delgado B, Cuadros M, Honrado E, Ruiz de la Parte A, Roncador G, Alves J, Castrillo JM, Rivas C, Benítez J.

Leukemia. 2005 Dec;19(12):2254-63.

PMID:
16270046
31.

Gross SDHB deletions in patients with paraganglioma detected by multiplex PCR: a possible hot spot?

Cascón A, Montero-Conde C, Ruiz-Llorente S, Mercadillo F, Letón R, Rodríguez-Antona C, Martínez-Delgado B, Delgado M, Díez A, Rovira A, Díaz JA, Robledo M.

Genes Chromosomes Cancer. 2006 Mar;45(3):213-9.

PMID:
16258955
32.

Allelic expression and quantitative RT-PCR study of TAp73 and DeltaNp73 in non-Hodgkin's lymphomas.

Cuadros M, Ribas G, Fernández V, Rivas C, Benitez J, Martinez-Delgado B.

Leuk Res. 2006 Feb;30(2):170-7. Epub 2005 Aug 3.

PMID:
16083956
33.

Identification of amplified and highly expressed genes in amplicons of the T-cell line huT78 detected by cDNA microarray CGH.

Meléndez B, Martínez-Delgado B, Cuadros M, Fernández V, Díaz-Uriarte R, Benítez J.

Mol Cancer. 2005 Jan 18;4(1):5.

34.

Gene expression analysis of chromosomal regions with gain or loss of genetic material detected by comparative genomic hybridization.

Meléndez B, Díaz-Uriarte R, Cuadros M, Martínez-Ramírez A, Fernández-Piqueras J, Dopazo A, Cigudosa JC, Rivas C, Dopazo J, Martínez-Delgado B, Benítez J.

Genes Chromosomes Cancer. 2004 Dec;41(4):353-65.

PMID:
15382261
35.

Expression profiling of T-cell lymphomas differentiates peripheral and lymphoblastic lymphomas and defines survival related genes.

Martinez-Delgado B, Meléndez B, Cuadros M, Alvarez J, Castrillo JM, Ruiz De La Parte A, Mollejo M, Bellas C, Diaz R, Lombardía L, Al-Shahrour F, Domínguez O, Cascon A, Robledo M, Rivas C, Benitez J.

Clin Cancer Res. 2004 Aug 1;10(15):4971-82.

36.

Coincidental LOH regions in mouse and humans: evidence for novel tumor suppressor loci at 9q22-q34 in non-Hodgkin's lymphomas.

Meléndez B, Cuadros M, Robledo M, Rivas C, Fernández-Piqueras J, Martínez-Delgado B, Benítez J.

Leuk Res. 2003 Jul;27(7):627-33.

PMID:
12681362
37.

Characterization of the A673 cell line (Ewing tumor) by molecular cytogenetic techniques.

Martínez-Ramírez A, Rodríguez-Perales S, Meléndez B, Martínez-Delgado B, Urioste M, Cigudosa JC, Benítez J.

Cancer Genet Cytogenet. 2003 Mar;141(2):138-42.

PMID:
12606131
38.

Molecular study of a new family with hereditary renal cell carcinoma and a translocation t(3;8)(p13;q24.1).

Meléndez B, Rodríguez-Perales S, Martínez-Delgado B, Otero I, Robledo M, Martínez-Ramírez A, Ruiz-Llorente S, Urioste M, Cigudosa JC, Benítez J.

Hum Genet. 2003 Feb;112(2):178-85. Epub 2002 Nov 13.

PMID:
12522559
39.

Complex cytogenetic abnormalities including telomeric associations and MEN1 mutation in a pediatric ependymoma.

Urioste M, Martínez-Ramírez A, Cigudosa JC, Colmenero I, Madero L, Robledo M, Martínez-Delgado B, Benítez J.

Cancer Genet Cytogenet. 2002 Oct 15;138(2):107-10.

PMID:
12505253
40.

Frequent inactivation of the p73 gene by abnormal methylation or LOH in non-Hodgkin's lymphomas.

Martinez-Delgado B, Melendez B, Cuadros M, Jose Garcia M, Nomdedeu J, Rivas C, Fernandez-Piqueras J, Benítez J.

Int J Cancer. 2002 Nov 1;102(1):15-9.

41.

Different incidence and pattern of p15INK4b and p16INK4a promoter region hypermethylation in Hodgkin's and CD30-Positive non-Hodgkin's lymphomas.

García MJ, Martínez-Delgado B, Cebrian A, Martínez A, Benítez J, Rivas C.

Am J Pathol. 2002 Sep;161(3):1007-13.

42.

A rapid and easy method for multiple endocrine neoplasia type 1 mutation detection using conformation-sensitive gel electrophoresis.

Arancha C, Ruíz-Llorente S, Cascón A, Osorio A, Martínez-Delgado B, Benítez J, Robledo M.

J Hum Genet. 2002;47(4):190-5.

PMID:
12166655
43.

Multiplex-polymerase chain reaction assay for the detection of prognostically significant translocations in acute lymphoblastic leukemia.

Marín C, Martínez-Delgado B, Meléndez B, Larrayoz MJ, Martínez-Ramírez A, Robledo M, Cigudosa JC, Calasanz MJ, Benítez J.

Haematologica. 2001 Dec;86(12):1254-60.

44.

Chromosomal changes pattern and gene amplification in T cell non-Hodgkin's lymphomas.

Renedo M, Martinez-Delgado B, Arranz E, Garcia M, Urioste M, Martinez-Ramirez A, Rivas C, Cigudosa JC, Benitez I.

Leukemia. 2001 Oct;15(10):1627-32.

PMID:
11587222
45.
46.

[Distribution of dominant hereditary ataxias and Friedreich's ataxia in the Spanish population].

Mayo Cabrero D, Hernández Cristóbal J, Cantarero Duque S, Martínez Delgado B, Urioste Azcorra M, Robledo Batanero M, García-Ruiz Espiga P, Benítez Ortiz J.

Med Clin (Barc). 2000 Jun 24;115(4):121-5. Spanish.

PMID:
10996881
47.

Hypermethylation of P16ink4a and P15ink4b genes as a marker of disease in the follow-up of non-Hodgkin's lymphomas.

Martinez-Delgado B, Richart A, García MJ, Robledo M, Osorio A, Cebrian A, Rivas C, Benitez J.

Br J Haematol. 2000 Apr;109(1):97-103.

PMID:
10848787
48.

[MLL rearrangements in acute leukemias].

Urioste M, Arranz E, Martínez-Delgado B, Soto C, Román A, Pérez I, Mayayo M, Pérez-Pons C, Barroso A, Benítez J.

Sangre (Barc). 1999 Dec;44(6):464-8. Spanish.

PMID:
10822761
49.

Identification by comparative genomic hybridization of genetic changes involved in tumoral progression of a T-cell non-Hodgkin lymphoma.

Arranz E, Martínez-Delgado B, Richart A, Osorio A, Cebrián A, Robledo M, Rivas C, Benítez J.

Cancer Genet Cytogenet. 2000 Feb;117(1):41-4.

PMID:
10700865
50.

[Identification of a de novo mutation in a patient without von Hippel-Lindau syndrome: clinical and diagnostic implications].

Cebrián A, Ruiz Barnés P, Osorio A, Martínez-Delgado B, Benítez J, Robledo M.

Neurologia. 1999 Aug-Sep;14(7):362-5. Spanish.

PMID:
10570625

Supplemental Content

Loading ...
Support Center